🇺🇸 FDA
Pipeline program

the ginsenoside Rg3

EHBH-RCT-2011-002

Unknown small_molecule completed

Quick answer

the ginsenoside Rg3 for Stage I Hepatocellular Carcinoma is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Stage I Hepatocellular Carcinoma
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials